Zercepac identity
The active ingredient recorded for this profile is Trastuzumab. Confirm the prescribed brand or ingredient before comparing packages.
Oncology medication reference
Zercepac price reference.
Zercepac (Trastuzumab) has 1 European package reference in this catalog. The listed 420 mg powder for solution for infusion · 1 unit reference is €3,369.56. No source-supported U.S. cash comparison is published for this profile; the European references should be reviewed package by package. Figures are informational, not a quote or supply guarantee.
Estimated medicine cost range€3,369.56
Source-supported U.S. cash contextNot listed
Estimated price differenceCase-specific comparison
Last recorded source review
Reference profile
Clear information.
Case-specific review.
The listed 420 mg powder for solution for infusion · 1 unit reference is €3,369.56. These figures are catalog references, not an offer to sell or a guarantee of supply. The correct product, package, destination, licensed provider and importer must be reviewed for each request.
Package-level price scope
The listed 420 mg powder for solution for infusion · 1 unit reference is €3,369.56. Strength, dosage form and quantity can materially change a like-for-like comparison.
Comparison evidence
No source-supported U.S. cash comparison is published for this profile; the European references should be reviewed package by package.
Package references
Zercepac listed formats
European figures are dated estimated medicine cost references. U.S. cash context appears only where the catalog retains source provenance; compare the exact strength, form and quantity.
| Package reference | Estimated medicine cost reference | Comparable U.S. cash reference | Estimated difference | Source notes | Select |
|---|---|---|---|---|---|
| 420 mg powder for solution for infusion · 1 unit Accord Healthcare GmbH · PZN 16768105 | €3,369.56 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
Data scopeReference information, not a quote
Displayed amounts are dated catalog references and may not include every tax, dispensing, shipping or route-specific cost. Exact identity, availability, prescription, destination and import route require separate review. U.S. amounts are shown only for records with retained comparison provenance. US Med Access does not dispense or sell medicines and provides no medical advice. Review the pricing and data methodology before comparing packages.
How the references are preparedSources and editorial responsibility
Where this Zercepac reference comes from
US Med Access publishes this page as an independent reference-information provider. Package records are retained with their available source notes and review dates; missing provenance is stated rather than inferred.
- Publisher and author
- US Med Access editorial team
- Recorded source review
- Reference scope
- 1 active European package record
Frequently asked questions
Zercepac price and package questions
Direct answers based on the package records shown on this page. They do not replace medical, regulatory or dispensing advice.
01What is the listed Zercepac price in Europe?
This catalog lists one European package reference at €3,369.56: 420 mg powder for solution for infusion · 1 unit. It is a dated information reference, not a live quote or sale offer.
02Does this page include a U.S. cash-price comparison for Zercepac?
No source-supported U.S. cash-price comparison is published for this profile. US Med Access does not estimate a U.S. figure when the catalog lacks adequate provenance.
03Are the listed Zercepac amounts a quote or sale offer?
No. They are informational catalog references. US Med Access is an independent sourcing consultant and does not sell or dispense medicines. Current availability, route, prescription and total cost require separate review.
04How do I request the correct Zercepac package?
Select the row that matches the prescribed strength, dosage form and quantity, then include the destination and request details. A package-level review is required before any next step.
Availability and logistics
Need a package-level review?
Start with the medication, package and destination. The sourcing team will assess the specific request without promising a supply, import or delivery outcome.